Wilmington Savings Fund Society FSB Takes Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Wilmington Savings Fund Society FSB purchased a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 2,819 shares of the company’s stock, valued at approximately $40,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of TAK. Public Employees Retirement System of Ohio acquired a new position in shares of Takeda Pharmaceutical during the third quarter worth $601,000. Verition Fund Management LLC acquired a new position in Takeda Pharmaceutical in the 3rd quarter worth $1,533,000. HighTower Advisors LLC boosted its position in Takeda Pharmaceutical by 199.5% in the 3rd quarter. HighTower Advisors LLC now owns 122,587 shares of the company’s stock valued at $1,744,000 after buying an additional 81,653 shares during the last quarter. XTX Topco Ltd acquired a new stake in shares of Takeda Pharmaceutical during the third quarter valued at about $957,000. Finally, Van ECK Associates Corp increased its position in shares of Takeda Pharmaceutical by 21.1% during the second quarter. Van ECK Associates Corp now owns 2,040,829 shares of the company’s stock worth $26,408,000 after acquiring an additional 356,069 shares during the last quarter. Hedge funds and other institutional investors own 9.17% of the company’s stock.

Takeda Pharmaceutical Trading Up 0.7 %

Shares of TAK opened at $13.10 on Monday. Takeda Pharmaceutical Company Limited has a one year low of $12.57 and a one year high of $15.08. The stock has a 50-day moving average price of $13.70 and a 200 day moving average price of $13.88. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.77 and a current ratio of 1.28. The company has a market capitalization of $41.68 billion, a P/E ratio of 22.59, a P/E/G ratio of 0.25 and a beta of 0.51.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.